通过子宫内膜异位症进入卵巢癌的免疫路径
Mariana Santos Calmon1, Fabian Fellipe Bueno Lemos1, Marcel Silva Luz1
1Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45029-094, Bahia, Brazil.
World journal of clinical oncology
|May 1, 2024
概括
子宫内膜异位症是一种炎症性疾病,具有类似癌症的特征,可能会先于卵巢癌的发展. 研究探讨了与子宫内膜异位症相关的卵巢癌的分子联系,免疫反应和免疫治疗.
科学领域:
- 妇科 妇科医生 妇科
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 子宫内膜异位症是一种依赖于雌激素的炎症性疾病,影响10-15%的生育年龄女性.
- 它与癌症具有共同的特征,并与卵巢癌风险增加有关,特别是清细胞,低度血清和子宫内膜类型.
- 连接子宫内膜异位症和子宫内膜异位症相关的卵巢癌 (EAOCs) 的分子途径尚未完全理解.
研究的目的:
- 审查有关将子宫内膜异位症与EAOCs联系起来的分子事件的当前数据.
- 专注于子宫内膜异位症免疫反应与癌症发展之间的关系.
- 检查EAOCs的潜在免疫疗法策略.
主要方法:
- 关于EAOC发展中的分子事件的文献综述.
- 对子宫内膜异位症和癌症免疫反应机制的分析.
- 探索免疫疗法的最新进展.
主要成果:
- 子宫内膜异位症和EAOCs可能通过氧化应激,炎症和高雌激素主义联系在一起.
- 免疫反应在从子宫内膜异位症过渡到癌症中起着复杂的作用.
- 免疫疗法显示了未来治疗EAOCs的潜力.
结论:
- 了解子宫内膜异位症,免疫和癌症之间的分子相互作用至关重要.
- 针对炎症和氧化应激路径可能提供治疗途径.
- 对免疫治疗的进一步研究可能会提高EAOCs的治疗疗效.
相关概念视频
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Hormonal Regulation of the Menstrual Cycle
346
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
346
Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


